18,836 results
Search Results
2. Response to paper by Kelly et al “The opioid receptor pharmacology of GSK1521498 compared to other ligands with different effects on compulsive reward-related behaviors” published in Psychopharmacology 232, 305–314, 2014
3. Ethanol and MDMA: a comment on the paper by Dumont et al.
4. Ethanol and MDMA: a comment on the paper by Izco et al.
5. Awards given to most frequently cited papers in Psychopharmacology
6. Comment on the paper by Horowski and Dorow
7. Residual effects of zopiclone on driving performance using a standardized driving simulator among healthy volunteers
8. Cardiac slowing and acute tryptophan depletion: a comment on the paper by van der Veen et al
9. Response to paper by Kelly et al 'The opioid receptor pharmacology of GSK1521498 compared to other ligands with different effects on compulsive reward-related behaviors' published in Psychopharmacology 232, 305–314, 2014
10. Cardiac slowing and acute tryptophan depletion: a comment on the paper by van der Veen et al.
11. Awards given to most frequently cited papers in Psychopharmacology
12. Ethanol and MDMA: a comment on the paper by Dumont et al
13. Ethanol and MDMA: a comment on the paper by Izco et al
14. Comment on the paper by Horowski and Dorow
15. The effect of e-cigarettes on cognitive function: a scoping review
16. Effect of chronic delivery of the NOP/MOR partial agonist AT-201 and NOP antagonist J-113397 on heroin relapse in a rat model of opioid maintenance
17. Emerging roles of cannabinoid receptor CB2 receptor in the central nervous system: therapeutic target for CNS disorders
18. Evaluating possible ‘next day’ impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial
19. Dual-step pharmacological intervention for traumatic-like memories: implications from D-cycloserine and cannabidiol or clonidine in male and female rats
20. Fear generalization modulated by shock intensity and protein synthesis inhibitor
21. Psychedelic-assisted psychotherapy: where is the psychotherapy research?
22. In Memoriam Roy W. Pickens 1939–2022.
23. Negative reinforcement via motivational withdrawal is the driving force behind the transition to addiction
24. Policosanol protects against Alzheimer’s disease-associated spatial cognitive decline in male rats: possible involved mechanisms
25. C57BL/6J offspring mice reared by a single-mother exhibit, compared to mice reared in a biparental parenting structure, distinct neural activation patterns and heightened ethanol-induced anxiolysis
26. Novel rat model of gaming disorder: assessment of social reward and sex differences in behavior and c-Fos brain activity
27. Phosphodiesterase inhibitors in psychiatric disorders.
28. Sexual satiety modifies methamphetamine-induced locomotor and rewarding effects and dopamine-related protein levels in the striatum of male rats.
29. Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review.
30. A time of promise, a time of promises: ethical issues in advancing psychopharmacological research.
31. Operant social seeking to a novel peer after social isolation is associated with activation of nucleus accumbens shell in rats
32. Regulation of human research with LSD in the United States (1949-1987)
33. Set and setting in microdosing: an oft-overlooked principle.
34. Targeting neuronal nitric oxide synthase and the nitrergic system in post-traumatic stress disorder.
35. Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.
36. Neuroimaging of opioid exposure: a review of preclinical animal models to inform addiction research
37. Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty21.
38. Physiological dependence to mitragynine indicated by a rapid cross-dependence procedure with heroin-dependent mice.
39. Neuroprotective effect of salidroside on hippocampal neurons in diabetic mice via PI3K/Akt/GSK-3β signaling pathway
40. Methamphetamine alters nucleus accumbens neural activation to monetary loss in healthy young adults
41. Importance of additional behavioral observation in psychopharmacology: a case study on agomelatine’s effects on feedback sensitivity in probabilistic reversal learning in rats
42. Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry
43. Opposite environmental gating of the experienced utility ('liking') and decision utility ('wanting') of heroin versus cocaine in animals and humans: implications for computational neuroscience.
44. Improved multiparameter models of drug effects on response rate under multiple variable interval schedules: evidence from rat studies.
45. Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment.
46. Nicotine issues.
47. Cannabidiol: pharmacology and therapeutic targets.
48. Ablation of olfactory bulb glutamatergic neurons induces depressive-like behaviors and sleep disturbances in mice
49. The effect of varenicline on mood and cognition in smokers with HIV
50. Rescuing the attentional performance of rats with cholinergic losses by the M1 positive allosteric modulator TAK-071
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.